1. Allegra JC, Lippman ME, Simon R, Thompson EB, Barlock A, Green L, Huff KK, Do HM, Aitken S, Warren R: Association between steroid hormone receptor status and disease free interval in breast cancer. Cancer Treat Rep 63: 1271–1277, 1979
2. Meyer JS, Lee TY: Relationships of S-phase fraction of breast carcinoma in relapse to duration of remissions, estrogen receptor content, therapeutic responsiveness, and duration of survival. Cancer Res 40: 1890–1896, 1980
3. Coulson PB, Thornthwaite JT, Woolley TW, Sugarbaker EV, Seckinger D: Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival. Cancer Res 44: 4187–4196, 1984
4. Hedley DW, Rugg CA, Alun BP, Taylor IW: Influence of cellular DNA content on disease-free survival of stage II breast cancer patients. Cancer Res 44: 5395–5398, 1984
5. Ewers SB, Langstrom E, Baldetop B, Killander D: Flow cytometric DNA analysis in primary breast carcinomas and clinicopathological correlations. Cytometry 5: 408–419, 1984